Neurogene to Participate in Upcoming Investor Conferences

Core Viewpoint - Neurogene Inc. is focused on developing genetic medicines for patients with rare neurological diseases and is actively engaging with investors through upcoming conferences [1] Group 1: Company Participation - Company management will participate in the Guggenheim Emerging Outlook: Biotech Summit, which includes a fireside chat and investor meetings [1] - The date for the Guggenheim conference is set for Thursday, February 12 at 9:00 a.m. ET [1] - Additionally, the company will be present at the TD Cowen 46th Annual Health Care Conference [1]